No significant change seen in attributable risk of female sex for operative mortality, composite of operative mortality and morbidity from 2011 to 2020
Targeted Therapies Seem Beneficial for Immune Checkpoint Inhibitor-Related Myotoxicity
Myotoxicity-related fatality rate 3.4 percent after institution of screening coupled with active ventilation, treatment